AUG Pharma
AUG Pharma is an Egyptian pharmaceutical manufacturer producing 58+ branded products across dermatology, supplements, cardiovascular, digestive, anti-diabetic, and men's/women's health, serving healthcare providers and patients in Egypt and expanding across the MENA region.
- Company typePrivate
- Founded2006
- HeadquartersGîza, Egypt
- Headcount501–1,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What AUG Pharma does
AUG Pharma is an Egyptian pharmaceutical manufacturing company founded in 2006 and headquartered in Gîza, Egypt, with 501–1,000 employees. The company manufactures and distributes a diversified portfolio of 58+ branded pharmaceutical products spanning dermatology (under the AUG-Derma sub-brand), nutritional supplements and immunity products (Sanso range), men's health (Dorectafil, DAPOXTARD), women's health (Sanso Folic, Sanso Hematinic), cardiovascular (Aspirin AUG-Pharma), anti-diabetic (DIBAVALLY PLUS), digestive system (ZURCAL, PROTOLANS, Pantoprazole Sala IV, G-SAC), orthopedic (Joint Care, Hot Strike Gel), and anti-inflammatory/analgesics (AUGCETAMIDE). The company operates its own manufacturing facility with pharmacovigilance and R&D functions, holds ISO 9001:2008 certification, and has obtained Saudi FDA (SFDA) approval enabling cross-border distribution.
AUG Pharma serves healthcare providers (physicians, dermatologists, pediatricians, gastroenterologists) and patients through a partner-driven, multi-channel distribution model. Primary GTM is event- and KOL-driven (active participation in conferences such as the Delta Union of Pediatrics Conference, Aswan Gastro Hub 2025, and PEACE Conference that drew 600+ dermatologists) combined with traditional pharmaceutical distribution channels in Egypt and a strategic partnership with Libyana for Libyan market entry. The company is led by CEO & President Dr. Ashraf Osman and Co-Founder & Country Director Ahmed Barakat, with no disclosed external investors or parent company. Revenue is generated through one-time product sales (physical pharmaceutical units) through wholesale/distribution intermediaries; pricing is not publicly disclosed. Strategic positioning targets affordable, high-quality medications across multiple therapeutic areas with an explicit MENA-region expansion thesis, evidenced by Libya market entry and SFDA approval.
AUG Pharma firmographics
Firmographics- Name
- AUG Pharma
- Legal name
- AUG Pharma
- Website
- https://augpharma.com
- Company type
- Private
- Founded year
- 2006
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- AUG Pharma is an Egyptian pharmaceutical manufacturer producing 58+ branded products across dermatology, supplements, cardiovascular, digestive, anti-diabetic, and men's/women's health, serving healthcare providers and patients in Egypt and expanding across the MENA region.
- Ownership category
- akta.pro rank
AUG Pharma industry classification
Industry- Product category
- Pharmaceutical Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254), Drugs and Druggists' Sundries Merchant Wholesalers (424210)
- SIC
- Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Oral Solid Dose (OSD) Generics (HLAIABAD)
- akta.pro secondary industries
- Specialty Care Pharmaceuticals (HLAIAAAB), Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)
Keywords
Where AUG Pharma is headquartered
LocationHeadquarters
- HQ city
- Gîza
- HQ country
- Egypt
- HQ region
- Africa
Offices1 record
Markets served
AUG Pharma business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Pharmaceutical Product Sales: AUG Pharma generates revenue through the manufacturing and sale of pharmaceutical products across multiple therapeutic categories including dermatology, pediatrics, digestive system, orthopedic, anti-inflammatory, cardiovascular, endocrine/diabetic, immunity, and women's/men's health.
Go-to-market motion2 records
Distribution channels2 records
Marketing channels3 records
AUG Pharma product offering
Product offeringCore offering
AUG Pharma is an Egyptian pharmaceutical manufacturer that formulates, produces, and distributes a broad portfolio of finished dosage pharmaceutical products across multiple therapeutic categories including dermatology, cardiovascular, endocrine/diabetic, digestive system, orthopedic, anti-inflammatory/analgesics, men's health, women's health, pediatrics, and immunity. The company operates its own manufacturing facility in Egypt and sells branded product lines under the AUG-Pharma, AUG Derma, and Sanso sub-brands.
Product overview
AUG Pharma is an Egyptian pharmaceutical company with a diverse portfolio of over 58 products spanning multiple therapeutic categories. The product portfolio includes: dermatology products under the AUG-Derma sub-brand (Urea Complete Repair Cream, Vaseline Cream, Panthenol, Brucare, Silicon Gel, Baby Cream with Aloe-Vera, Sunscreen); the Sanso Range of nutritional supplements including collagen-based skincare products (Collagen Cream, Collagen Cleansing Gel, Hyaluronic Acid + Vitamin C Serum), immunity products (Sanso Immune, Sanso Immune Plus, Sanso C Plus), vitamin supplements (SANSOVIT Iron, SANSOVIT MultiVitamin, Sanso Lactoferrin), and mineral supplements (Sansocal-D, Sanso D3, Sanso D3 Plus, Sanso Magnesium); women's health products (Sanso Folic, Sanso Hematinic); men's health products (Dorectafil for erectile dysfunction, DAPOXTARD for premature ejaculation); cardiovascular products (Aspirin AUG-Pharma); anti-diabetic products (DIBAVALLY PLUS); digestive system products (ZURCAL, PROTOLANS, Pantoprazole Sala IV, G-SAC); orthopedic products (Joint Care, JointCare Plus, Hot strike Gel, Ibuprosol Topical Gel, NOXILORN); anti-inflammatory analgesics (AUGCETAMIDE); and other products including Faktu Rectal Suppository and Lactulose AUG-Pharma. The company operates its own manufacturing facility and has achieved international certifications including ISO 9001:2008 quality management system.
Differentiator
Problem solved
Functional benefit
Brands
- AUG Derma: Dermatology product line including moisturizers, sunscreen, and skincare treatments
- Sanso
- AUG-Pharma
Products and services
- AUG Derma Dermatology product line covering skin moisturizing, sun protection, scar treatment, baby care, and skin healing formulations for patients and healthcare providers.
- Sanso Range
Companies that use AUG Pharma
Customer profileNamed customers12 records
Segments1 record
Ideal customer profiles1 record
AUG Pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AUG Pharma partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and minor.
- LibyanacoreAUG Pharma entered into a strategic collaboration with Libyana for importing pharmaceutical and medical equipment as part of their expansion into the Libyan market. The partnership aligns with AUG Pharma's vision to expand across the MENA region and enhance access to essential medications. Initial portfolio includes treatments for chronic diseases, infections, and cardiovascular conditions.
- VitafoodsminorPartner company shown on AUG Pharma's partner section of the website.
- PharmathlenminorPartner company shown on AUG Pharma's partner section of the website.
- Cigalah Medical IndustriesminorPartner company shown on AUG Pharma's partner section of the website.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
AUG Pharma competitors and assessment
Company assessmentRegional players
- Julphar (Gulf Pharmaceutical Industries): UAE-based MENA pharmaceutical manufacturer with branded generics across multiple therapeutic areas; comparable in product mix and regional GCC/MENA focus, though headquartered in a different GCC market.
- Tabuk Pharmaceuticals: Saudi-based pharmaceutical manufacturer producing branded generics across multiple therapeutic categories with MENA distribution; a relevant comparable for AUG Pharma's Saudi expansion strategy.
- SPIMACO (Saudi Pharmaceutical Industries & Medical Appliances): Saudi-listed pharmaceutical manufacturer with branded generics and licensing partnerships; the principal local incumbent in AUG Pharma's targeted Saudi market, comparable in generic business model.
Direct peers
- Eva Pharma: Egyptian pharmaceutical manufacturer with broad therapeutic portfolio and MENA/Africa export presence; the closest direct competitor in scale, product mix, and Egypt-based manufacturing footprint.
- EIPICO (Egyptian International Pharmaceutical Industries): Major Egyptian generic and specialty pharmaceutical manufacturer with a wide therapeutic portfolio and MENA/Africa exports; directly comparable in product categories, manufacturing scope and regional market focus.
- Marcyrl Pharmaceutical Industries: Egyptian pharmaceutical manufacturer with a diversified portfolio of branded generics across cardiovascular, anti-infective and other therapeutic areas; comparable in scale, manufacturing model and regional ambition.
- Amoun Pharmaceutical: Egypt-based pharmaceutical manufacturer producing branded generics and OTC products across multiple therapeutic areas; directly comparable in business model and target markets.
- Pharco Pharmaceuticals: One of Egypt's largest pharmaceutical manufacturers producing branded generics across multiple therapeutic categories, with regional MENA distribution; directly comparable in business model and customer base.
Emerging players
- Mepaco Pharma: Egypt-based pharmaceutical manufacturer focused on specialty and branded generics; smaller in scale but comparable in product categories and Egypt/MENA go-to-market approach.
Broad incumbents
- Hikma Pharmaceuticals: Leading MENA-headquartered (Jordan) generic and specialty pharmaceutical company with manufacturing in MENA and US; broader scale but overlapping product categories (cardiovascular, anti-infective, oncology) and target markets.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
AUG Pharma social profiles
Digital presenceAUG Pharma compliance and trust
Trust signalCompliance1 record
AUG Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
AUG Pharma leadership team
Management profileNumber of profiles
Profiles1 record
AUG Pharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
AUG Pharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about AUG Pharma
What does AUG Pharma do?
AUG Pharma is an Egyptian pharmaceutical manufacturer that formulates, produces, and distributes a broad portfolio of finished dosage pharmaceutical products across multiple therapeutic categories including dermatology, cardiovascular, endocrine/diabetic, digestive system, orthopedic, anti-inflammatory/analgesics, men's health, women's health, pediatrics, and immunity. The company operates its own manufacturing facility in Egypt and sells branded product lines under the AUG-Pharma, AUG Derma, and Sanso sub-brands.
Is AUG Pharma a public or private company?
AUG Pharma is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was AUG Pharma founded?
AUG Pharma was founded in 2006. It employs 501 to 1,000 people.
Where is AUG Pharma based?
AUG Pharma is headquartered in Gîza, Egypt, in the Africa region.
How does AUG Pharma make money?
One revenue line is on record: pharmaceutical Product Sales.
Who are AUG Pharma's main competitors?
Regional players on record are Julphar (Gulf Pharmaceutical Industries), Tabuk Pharmaceuticals and SPIMACO (Saudi Pharmaceutical Industries & Medical Appliances). Direct peers are Eva Pharma, EIPICO (Egyptian International Pharmaceutical Industries), Marcyrl Pharmaceutical Industries, Amoun Pharmaceutical and Pharco Pharmaceuticals. Mepaco Pharma is listed as an emerging player. Hikma Pharmaceuticals is listed as a broad incumbent.
Does AUG Pharma have an API?
No public API is recorded for AUG Pharma.
What industry is AUG Pharma in?
AUG Pharma's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIABAD, Oral Solid Dose (OSD) Generics, with a secondary code of HLAIAAAB, Specialty Care Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.